• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Correlation of Serum Levels of Vitronectin, Malondialdehyde and Hs- CRP With Disease Severity in Coronary Artery Disease.血清玻连蛋白、丙二醛和超敏C反应蛋白水平与冠状动脉疾病严重程度的相关性
J Cardiovasc Thorac Res. 2015;7(3):113-7. doi: 10.15171/jcvtr.2015.24.
2
Evaluation of Serum Levels of Inflammation, Fibrinolysis and Oxidative Stress Markers in Coronary Artery Disease Prediction: A Cross-Sectional Study.评估炎症、纤溶和氧化应激标志物在冠心病预测中的血清水平:一项横断面研究。
Arq Bras Cardiol. 2019 Aug 29;113(4):667-674. doi: 10.5935/abc.20190159. eCollection 2019.
3
High sensitive C-reactive protein, adiponectin, and urine albumin excretion rate in Chinese coronary artery disease patients with different glucose tolerance status.不同糖耐量状态的中国冠心病患者的高敏C反应蛋白、脂联素及尿白蛋白排泄率
Chin Med J (Engl). 2008 Dec 20;121(24):2509-16.
4
C-reactive protein associated with coronary artery disease in Iranian patients with angiographically defined coronary artery disease.在经血管造影确诊为冠状动脉疾病的伊朗患者中,C反应蛋白与冠状动脉疾病相关。
Clin Lab. 2007;53(1-2):49-56.
5
Association of myeloperoxidase, homocysteine and high-sensitivity C-reactive protein with the severity of coronary artery disease and their diagnostic and prognostic value.髓过氧化物酶、同型半胱氨酸及高敏C反应蛋白与冠状动脉疾病严重程度的关联及其诊断和预后价值。
Exp Ther Med. 2020 Aug;20(2):1532-1540. doi: 10.3892/etm.2020.8817. Epub 2020 May 29.
6
Variation in high-sensitivity C-reactive protein levels over 24 hours in patients with stable coronary artery disease.稳定性冠心病患者24小时内高敏C反应蛋白水平的变化
Tex Heart Inst J. 2010;37(1):42-8.
7
Relationship between serum high sensitivity C-reactive protein with angiographic severity of coronary artery disease and traditional cardiovascular risk factors.血清高敏 C 反应蛋白与冠状动脉疾病血管造影严重程度及传统心血管危险因素的关系。
J Cell Physiol. 2019 Jul;234(7):10289-10299. doi: 10.1002/jcp.27945. Epub 2018 Dec 12.
8
Estimation of Serum Malondialdehyde (a Marker of Oxidative Stress) as a Predictive Biomarker for the Severity of Coronary Artery Disease (CAD) and Cardiovascular Outcomes.血清丙二醛(氧化应激标志物)作为冠状动脉疾病(CAD)严重程度及心血管结局的预测生物标志物的评估
Cureus. 2024 Sep 19;16(9):e69756. doi: 10.7759/cureus.69756. eCollection 2024 Sep.
9
Relationship between high-sensitivity C-reactive protein serum levels and the severity of coronary artery stenosis in patients with coronary artery disease.冠心病患者血清高敏C反应蛋白水平与冠状动脉狭窄程度的关系
ARYA Atheroscler. 2016 Sep;12(5):231-237.
10
Markers of low-grade inflammation and soluble cell adhesion molecules in Chinese patients with coronary artery disease.中国冠心病患者低度炎症标志物与可溶性细胞黏附分子
Can J Cardiol. 2004 Dec;20(14):1433-8.

引用本文的文献

1
The Dual Role of Oxidative Stress in Atherosclerosis and Coronary Artery Disease: Pathological Mechanisms and Diagnostic Potential.氧化应激在动脉粥样硬化和冠状动脉疾病中的双重作用:病理机制与诊断潜力
Antioxidants (Basel). 2025 Feb 26;14(3):275. doi: 10.3390/antiox14030275.
2
Chitosan-Based Nanoformulations: Preclinical Investigations, Theranostic Advancements, and Clinical Trial Prospects for Targeting Diverse Pathologies.壳聚糖基纳米制剂:针对多种病理的靶向治疗的临床前研究、治疗学进展和临床试验前景。
AAPS PharmSciTech. 2024 Nov 5;25(8):263. doi: 10.1208/s12249-024-02948-x.
3
Evaluating SORT1 and SESN1 genes expression in peripheral blood mononuclear cells and oxidative stress status in patients with coronary artery disease.评价冠心病患者外周血单个核细胞中 SORT1 和 SESN1 基因的表达及氧化应激状态。
BMC Genom Data. 2024 Nov 2;25(1):93. doi: 10.1186/s12863-024-01275-1.
4
The link between fear of disease progression and health promotion behaviors in patients with obstructive sleep apnea hypoventilation syndrome (OSAHS): the mediating role of social support.恐惧疾病进展与阻塞性睡眠呼吸暂停低通气综合征(OSAHS)患者健康促进行为之间的联系:社会支持的中介作用。
BMC Psychol. 2024 Oct 15;12(1):557. doi: 10.1186/s40359-024-02059-z.
5
A Novel RP-UHPLC-MS/MS Approach for the Determination of Tryptophan Metabolites Derivatized with 2-Bromo-4'-Nitroacetophenone.一种用于测定用2-溴-4'-硝基苯乙酮衍生化的色氨酸代谢物的新型反相超高效液相色谱-串联质谱法
Biomedicines. 2024 May 2;12(5):1003. doi: 10.3390/biomedicines12051003.
6
Exploring the role of Sirtuin 3 gene polymorphisms and oxidative stress markers in the susceptibility to coronary artery disease.探讨 Sirtuin 3 基因多态性和氧化应激标志物在冠心病易感性中的作用。
Mol Biol Rep. 2023 Nov;50(11):9221-9228. doi: 10.1007/s11033-023-08825-3. Epub 2023 Oct 6.
7
The Effect of Ginger Supplementation on the Improvement of Dyspeptic Symptoms in Patients With Functional Dyspepsia.补充生姜对改善功能性消化不良患者消化不良症状的影响。
Cureus. 2023 Sep 27;15(9):e46061. doi: 10.7759/cureus.46061. eCollection 2023 Sep.
8
Role of increased plasminogen activator inhibitor-1 and vitronectin in gestational diabetes mellitus.妊娠糖尿病中纤溶酶原激活物抑制剂-1 和玻连蛋白水平升高的作用。
Rev Assoc Med Bras (1992). 2023 Sep 18;69(9):e20230563. doi: 10.1590/1806-9282.20230563. eCollection 2023.
9
Clinical effects of cognitive behavioral therapy in heart failure patients: a meta-analysis of randomized controlled trials.认知行为疗法对心力衰竭患者的临床效果:一项随机对照试验的荟萃分析。
BMC Complement Med Ther. 2023 Aug 7;23(1):280. doi: 10.1186/s12906-023-04117-2.
10
Solid lipid nanoparticles, an effective carrier for classical antifungal drugs.固体脂质纳米粒,一种用于传统抗真菌药物的有效载体。
Saudi Pharm J. 2023 Jul;31(7):1167-1180. doi: 10.1016/j.jsps.2023.05.011. Epub 2023 May 19.

本文引用的文献

1
hs-CRP and oxidative stress in young CAD patients: A pilot study.年轻冠心病患者中的高敏C反应蛋白与氧化应激:一项初步研究。
Indian J Clin Biochem. 2008 Oct;23(4):334-6. doi: 10.1007/s12291-008-0073-8. Epub 2008 Dec 20.
2
Vitronectin concentrations predict risk in patients undergoing coronary stenting.纤连蛋白浓度可预测行冠脉支架置入术患者的风险。
Circ Cardiovasc Interv. 2009 Feb;2(1):14-9. doi: 10.1161/CIRCINTERVENTIONS.108.795799. Epub 2008 Dec 15.
3
Significant relationship between serum high-sensitivity C-reactive protein, high-density lipoprotein cholesterol levels and children with Kawasaki disease and coronary artery lesions.血清高敏 C 反应蛋白、高密度脂蛋白胆固醇水平与川崎病患儿及冠状动脉病变的相关性。
J Formos Med Assoc. 2009 Sep;108(9):719-24. doi: 10.1016/S0929-6646(09)60395-8.
4
Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.瑞舒伐他汀预防C反应蛋白升高的男性和女性发生血管事件。
N Engl J Med. 2008 Nov 20;359(21):2195-207. doi: 10.1056/NEJMoa0807646. Epub 2008 Nov 9.
5
Platelet adhesion receptors and their ligands in mouse models of thrombosis.血小板黏附受体及其在小鼠血栓形成模型中的配体。
Arterioscler Thromb Vasc Biol. 2007 Apr;27(4):728-39. doi: 10.1161/01.ATV.0000259359.52265.62. Epub 2007 Feb 1.
6
Vitronectin in atherosclerotic disease.动脉粥样硬化疾病中的玻连蛋白
Clin Chim Acta. 2006 Jun;368(1-2):77-83. doi: 10.1016/j.cca.2005.12.015. Epub 2006 Feb 7.
7
Circulating malondialdehyde-modified LDL and atherogenic lipoprotein profiles measured by nuclear magnetic resonance spectroscopy in patients with coronary artery disease.通过核磁共振光谱法测量冠心病患者循环中的丙二醛修饰低密度脂蛋白和致动脉粥样硬化脂蛋白谱。
Atherosclerosis. 2005 Mar;179(1):139-45. doi: 10.1016/j.atherosclerosis.2004.09.013. Epub 2004 Nov 13.
8
Evaluation of fibronectin, vitronectin, and leptin levels in coronary artery disease: impacts on thrombosis and thrombolysis.冠状动脉疾病中纤连蛋白、玻连蛋白和瘦素水平的评估:对血栓形成和溶栓的影响。
Clin Appl Thromb Hemost. 2005 Jan;11(1):63-70. doi: 10.1177/107602960501100107.
9
Urokinase-type plasminogen activator receptor is involved in mediating the apoptotic effect of cleaved high molecular weight kininogen in human endothelial cells.尿激酶型纤溶酶原激活物受体参与介导裂解的高分子量激肽原对人内皮细胞的凋亡作用。
Circ Res. 2004 May 14;94(9):1227-34. doi: 10.1161/01.RES.0000126567.75232.46. Epub 2004 Mar 25.
10
C-reactive protein elevation and disease activity in patients with coronary artery disease.冠状动脉疾病患者中C反应蛋白升高与疾病活动度
Eur Heart J. 2004 Mar;25(5):401-8. doi: 10.1016/j.ehj.2003.12.017.

血清玻连蛋白、丙二醛和超敏C反应蛋白水平与冠状动脉疾病严重程度的相关性

Correlation of Serum Levels of Vitronectin, Malondialdehyde and Hs- CRP With Disease Severity in Coronary Artery Disease.

作者信息

Yaghoubi Alireza, Ghojazadeh Morteza, Abolhasani Sakhavat, Alikhah Hossein, Khaki-Khatibi Fatemeh

机构信息

Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran.

Liver and Gastrointestinal Disease Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

出版信息

J Cardiovasc Thorac Res. 2015;7(3):113-7. doi: 10.15171/jcvtr.2015.24.

DOI:10.15171/jcvtr.2015.24
PMID:26430499
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4586597/
Abstract

INTRODUCTION

Vitronectin (VN), malondialdehyde (MDA) and high-sensitivity C-reactive rotein (hs-CRP) are cooperative agents involved in the atherosclerosis process. The study was conducted to assess the correlation of VN, MDA and hs-CRP with the severity of coronary artery disease (CAD).

METHODS

Parameters such as serum VN, MDA and hs-CRP were measured in 250 subjects including 200 patients with angiographically diagnosed CAD (50 subjects with non-significant CAD, 50 with single vessel disease, 50 with double vessel disease, and 50 with triple vessel disease) and 50 CAD-free subjects as a control group. Serum VN was measured with ELISA; MDA was measured based on reaction with thiobarbituric acid (TBA); and hs-CRP level was measured by a Commercial Kit by Immunoturbidimetry.

RESULTS

Serum VN, MDA and hs-CRP were significantly higher in patient groups compared to control group (P < .05). The mean value of MDA between 1 vessel and 3 vessel groups had significant difference (P = .01), also mean value of MDA between 2 vessel and control group and normal group showed significant difference (P < .001). The difference of MDA between 3 vessel and normal and 1 vessel and control group was significant (P < .001).

CONCLUSION

The association and correlation between VN, MDA and hs-CRP indicate their involvement in the atherosclerosis process that may lead to progression of CAD. Also, these findings suggested that serum levels of VN, MDA and hs-CRP can help as diagnostic and monitoring markers in CAD patients and as markers of disease severity.

摘要

引言

玻连蛋白(VN)、丙二醛(MDA)和高敏C反应蛋白(hs-CRP)是参与动脉粥样硬化过程的协同因子。本研究旨在评估VN、MDA和hs-CRP与冠状动脉疾病(CAD)严重程度的相关性。

方法

对250名受试者进行血清VN、MDA和hs-CRP等参数检测,其中包括200例经血管造影诊断为CAD的患者(50例非显著性CAD患者、50例单支血管病变患者、50例双支血管病变患者和50例三支血管病变患者)以及50例无CAD的受试者作为对照组。采用酶联免疫吸附测定法(ELISA)检测血清VN;基于与硫代巴比妥酸(TBA)的反应测定MDA;采用免疫比浊法通过商业试剂盒检测hs-CRP水平。

结果

与对照组相比,患者组的血清VN、MDA和hs-CRP显著更高(P <.05)。单支血管组和三支血管组之间的MDA平均值存在显著差异(P =.01),双支血管组与对照组及正常组之间的MDA平均值也显示出显著差异(P <.00)。三支血管组与正常组以及单支血管组与对照组之间的MDA差异显著(P <.001)。

结论

VN、MDA和hs-CRP之间的关联和相关性表明它们参与了可能导致CAD进展的动脉粥样硬化过程。此外,这些发现表明血清VN、MDA和hs-CRP水平可作为CAD患者的诊断和监测标志物以及疾病严重程度的标志物。